NICE Yes For Lynparza In England May Have 'Huge Impact' For Ovarian Cancer
Executive Summary
AstraZeneca and MSD's Lynparza can now be paid for through England’s Cancer Drugs Fund for use in women with advanced BRCA-mutated ovarian cancer when their disease is newly diagnosed and when the drug may have the potential to cure their disease.